AstraZeneca Datroway Wins EU Approval, 5-Month OS Gain
See more from StockTitan in Google Search…
AstraZeneca wins EU approval for Datroway in TNBC | AZN SEC Filing
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant…
AstraZeneca gets EU nod for Etcamah in breast cancer | AZN SEC Filing
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant…
Approved in EU for HER2 positive metastatic solid tumors
Enhertu (trastuzumab deruxtecan) has been approved in the European Union as a monotherapy for unresectable or metastatic HER2…